NMOSD

12 registered clinical trials studyying NMOSD — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD NCT07010302	Massachusetts General Hospital	Phase 4
Recruiting	A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In NCT05199688	Hoffmann-La Roche	Phase 3
Not Yet Recruiting	Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD) NCT07266051	Xiamen Hospital of Traditional Chinese Medicine	—
Not Yet Recruiting	Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder NCT07182409	First Affiliated Hospital of Chongqing Medical University	—
Not Yet Recruiting	Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light NCT06903130	National and Kapodistrian University of Athens	—
Recruiting	Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairmen NCT07087873	Xuanwu Hospital, Beijing	N/A
Active Not Recruiting	Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD NCT06724809	Alexion Pharmaceuticals, Inc.	Phase 3
Recruiting	Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912	Nanjing Bioheng Biotech Co., Ltd.	EARLY_Phase 1
Recruiting	Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies NCT05966467	Alexion Pharmaceuticals, Inc.	—
Active Not Recruiting	Comparative Study on AQP4 Antibody Detection Methods NCT06767020	First Affiliated Hospital of Chongqing Medical University	—
Terminated	A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention NCT05269667	Hoffmann-La Roche	Phase 4
Recruiting	Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) NCT06940323	University of California, San Francisco	—